openPR Logo
Press release

Ventricular Assist Devices Market Trend and Demands 2018 with Key Players: Terumo Medical Corporation, Medtronic, Abiomed, LivaNova

12-24-2018 10:15 AM CET | Health & Medicine

Press release from: Global Market Insights

Ventricular Assist Devices Market

Ventricular Assist Devices Market

Global Ventricular assist devices market is set to exceed USD 2.0 billion by 2024; according to a new research study published by Global Market Insights, Inc.

Recent technological advancements in the design and functioning of ventricular assist devices making it more efficient, risk-free and less invasive will lead to growing demand and adoption rate of the device. Improvements in the devices and the implantation procedures has reduced the health risk and increased the survival rate in patients. These rapid technological advancements will be one of the major factors for boosting the market growth in the near future.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/3014

Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis:
• Terumo Medical Corporation
• Medtronic
• Abiomed
• LivaNova
• Berlin Heart GmbH
• BiVACOR Inc
• Cardiobridge GmbH
• Cardiokinetix
• Evaheart, Inc.
• Maquet Getinge Group
• HeartWare Inc
• ReliantHeart Inc.
• SynCardia Systems, LLC
• Kalila Medical (Abbott Laboratories)

Left ventricular assist devices market held most of market share in the year 2017 and was valued over USD 829.9 million. Increase in number of people suffering from end-stage heart failure will result in growing demand and adoption rate for LVAD devices, enhancing the left ventricular assist devices market growth in the near future.

Right ventricular assist devices market is estimated to grow at a robust CAGR of 10.6% in the forthcoming years. Increase in number of people suffering from acute right ventricular failure will result in boosting the demand and adoption rate, thereby augmenting business growth in the near future.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/3014

Bridge-to-candidacy (BTC) therapy market held the maximum market share and was valued around at USD 316.4 million in the year 2017. Decrease in number of heart donors across the globe has resulted in people opting for ventricular assist devices, but the patients that are not listed for transplantation are provided BTC therapy. Increase in use of BTC therapy for severe heart failure patients needing ventricular assist device implantation urgently will enhance the market growth in the near future.

Destination therapy market is projected to witness considerable amount of growth at a CAGR of 10.8% during the forecast time period. Destination therapy provides long-term support to the patients and is one of the most advised therapies in the treatment of severe end-stage heart failure amongst the population. Several benefits provided such as high survival rate, better quality of life, cost-effectiveness and cost utility will be one of the major reasons for boosting the growth of ventricular assist devices market for destination therapy.

Browse Full Report Details @ https://www.gminsights.com/industry-analysis/ventricular-assist-devices-market

Ventricular assist devices market by Product
• Left ventricular assist devices (LVADs)
• Right ventricular assist devices (RVADs)
• Biventricular assist devices (BIVADs)
• Percutaneous Ventricular Assist Devices
• Total Artificial Heart

Ventricular assist devices market by Application
• Destination therapy
• Bridge-to-candidacy (BTC) therapy
• Bridge-to-transplant (BTT) therapy
• Bridge-to-recovery (BTR) therapy

Global Market Insights Inc. is a global market research and management consulting company catering to leading corporations, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development.

Global Market Insights, Inc.
4 North Main Street
Selbyville, Delaware 19975 USA
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email:sales@gminsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Ventricular Assist Devices Market Trend and Demands 2018 with Key Players: Terumo Medical Corporation, Medtronic, Abiomed, LivaNova here

News-ID: 1457840 • Views:

More Releases from Global Market Insights

Acoustic Diaphragm Market slated to observe traction for polypropylene material in earphones & loudspeakers
Acoustic Diaphragm Market slated to observe traction for polypropylene material …
With a seismic rise in the demand for consumer products such a loudspeakers, mobile phones and earphones, acoustic diaphragm market size is slated to surge in the next five years. Notably, acoustic diaphragm tends to inter-convert mechanical vibration to sounds and has become highly popular in headphones and speakers. Market penetration of materials such as paper, polycarbonate, polypropylene, carbon fiber and aluminum has become more pronounced in the past several
How will increasing demand for stainless steel transform the Ferroalloys Market outlook?
How will increasing demand for stainless steel transform the Ferroalloys Market …
One of the recent breakthroughs in the global ferroalloys market is the potential acquisition of Ferro Alloys Corporation by Vedanta- a natural resource company early this year. As per reliable sources, the acquisition is expected to complement Vedanta’s current steel business considering the fact that integration of Ferro manufacturing capabilities would offer the possibility to generate significant efficiencies. Meanwhile, yet other company, Boston Metal has declared having raised over USD 20
Polyphenylsulfone Market 2021 | Regional Insights & Growth Forecast To 2025
Polyphenylsulfone Market 2021 | Regional Insights & Growth Forecast To 2025
The polyphenylsulfone market will witness significant expansion with the rise in healthcare concerns and the growing requirement for biocompatible products. Polyphenylsulfone is a high-performance thermoplastic that is amorphous, heat-resistant, and transparent. It showcases high sterilization properties and is widely employed as an alternative for polyetheretheketone and polyaryletherketone. Furthermore, the polymer sees large adoption across various verticals of the healthcare sector to offer superior dimensional stability and higher resistance against
Cosmetic Contact Lens Market 2021: Industry Growth, Competitive Analysis, Future Prospects and Forecast 2024
Cosmetic Contact Lens Market 2021: Industry Growth, Competitive Analysis, Future …
Increasing trend of using colored contact lenses may have a positive impact on cosmetic contact lens market outlook. Rising popularity of customized lenses with attractive colors, shades and textures for improving eye appearance is likely to propel industry size. Proliferation of entertainment, online and social media platforms are helping boost the adoption of such lenses. Cosmetic contact lenses are available in several colors such as blue, green, brown, hazel, grey, violet

All 5 Releases


More Releases for Ventricular

Ventricular Assist Device Market Report Up tp 2031
Visiongain has published a new report on Ventricular Assist Device Market Report 2021-2031: Forecasts by Product (LVAD, RVAD, BiVAD, TAH), By Type of Flow (Pulsatile, Continuous), By Design, By Application. PLUS Profiles of Leading Pharma Contract Manufacturing Companies and Regional and Leading National Market Analysis. PLUS COVID-19 Recovery Scenarios. GlobalVentricular Assist Device market was valued at US$ xx billion in 2020 and is projected to reach at a market value of
Left Ventricular Dysfunction - Pipeline Review, H1 2018
Left Ventricular Dysfunction Overview Left ventricular dysfunction is the most common cause of congestive heart failure. Symptoms include fluid retention, dizziness, fatigue, weakness, irregular heart beat and congested lungs. Risk factors include high blood pressure, diabetes, sleep apnea, alcoholism and Left Ventricular Dysfunction. Click here for sample report @ https://www.wiseguyreports.com/sample-request/2811435-left-ventricular-dysfunction-pipeline-review-h1-2018 Top Companies mentioned Bayer AG Innopharmax Inc Mesoblast Ltd Novartis AG Quantum Genomics SA TiGenix NV Left Ventricular Dysfunction Industry Major Outlook Pharmaceutical and Healthcare latest pipeline guide Left Ventricular Dysfunction -
Left Ventricular Dysfunction - Pipeline Review, H1 2017
Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Left Ventricular Dysfunction - Pipeline Review, H1 2017, provides an overview of the Left Ventricular Dysfunction (Cardiovascular) pipeline landscape. Left ventricular dysfunction is the most common cause of congestive heart failure. Symptoms include fluid retention, dizziness, fatigue, weakness, irregular heart beat and congested lungs. Risk factors include high blood pressure, diabetes, sleep apnea, alcoholism and coronary artery disease. Report Highlights Publisher's Pharmaceutical and Healthcare
Global Ventricular Fibrillation Market 2021- Analysis and Trends
“Global Ventricular Fibrillation Market Research Report” Purchase This Report by calling ResearchnReports.com at +1-888-631-6977. Ventricular fibrillation is a heart rhythm problem that occurs when the heart beats with rapid, erratic electrical impulses. This causes pumping chambers in your heart (the ventricles) to quiver uselessly, instead of pumping blood. Together, all four chambers pump blood to and from the body. When the atria, the two upper chambers, contract at an excessively high
05-08-2017 | Health & Medicine
SA-BRC
Ventricular Assist Devices (VAD) Market Assessment
Ventricular assist devices (VAD) are mechanical pumps used to support patients with a weakened heart or in case of heart failure to temporarily maintain heart function. The devices helps in re-establishing normal hemodynamics under conditions involving damaged ventricle. Increasing trend for sedentary lifestyle, rising obesity population globally, lifestyle changes and various other factors have resulted an increase in cardiovascular disorders. This rising prevalence across the globe has been a major
Ventricular Assist Device Market: Global Markets & Advanced Technologies
North America Ventricular Assist Device Market: Overview Advance Heart Failure is characterized as weakening of the heart caused due to failure of the left ventricle, due to which the heart is unable to pump blood to different parts of the body. According to the AHA (American Heart Association), 5.7 Mn people in the U.S suffer from heart failure and 300,000 die each year of heart failure. Moreover, the AHA predicts